AIMS/HYPOTHESIS: Diabetes in pregnancy is linked to development of obesity in the offspring, but the mechanisms are not fully understood. Gestational diabetes mellitus (GDM) occurs when beta cells are unable to compensate for the normal insulin resistance of late pregnancy. In this study, we used a murine model of beta cell dysfunction to examine the effects of maternal GDM on phenotype in male offspring with and without an inherited predisposition for beta cell dysfunction. METHODS: Beta cell-specific aryl-hydrocarbon receptor nuclear translocator-null (βArnt) mice develop GDM from beta cell dysfunction. βArnt and control female mice were used to induce GDM and non-diabetic pregnancies, respectively. RESULTS: Offspring from GDM pregnancies became spontaneously obese on a normal-chow diet. They were heavier than offspring from non-diabetic pregnancies, with increased body fat. Respiratory exchange ratio (RER) was higher, indicating decreased capacity to switch to lipid oxidation. Metabolic rate in GDM offspring was decreased prior to onset of obesity. The phenotype was more pronounced in βArnt GDM offspring than in GDM offspring of control genotype, demonstrating an interaction between genotype and pregnancy exposure. βArnt GDM offspring had increased hypothalamic neuropeptide Y (Npy) and decreased pro-opiomelanocortin (Pomc) expression. Weight, body fat, insulin sensitivity and RER in all mice, and hypothalamic Npy in βArnt mice were significantly correlated with AUC of maternal late pregnancy glucose tolerance tests (p < 0.01), but not with litter size, maternal weight, triacylglycerol or pre-pregnancy glycaemia. CONCLUSIONS/ INTERPRETATION: In βArnt mice, exposure to GDM and inheritance of genetic beta cell dysfunction had additive effects on male offspring obesity; severity of the offspring phenotype correlated with maternal glycaemia.
AIMS/HYPOTHESIS: Diabetes in pregnancy is linked to development of obesity in the offspring, but the mechanisms are not fully understood. Gestational diabetes mellitus (GDM) occurs when beta cells are unable to compensate for the normal insulin resistance of late pregnancy. In this study, we used a murine model of beta cell dysfunction to examine the effects of maternal GDM on phenotype in male offspring with and without an inherited predisposition for beta cell dysfunction. METHODS: Beta cell-specific aryl-hydrocarbon receptor nuclear translocator-null (βArnt) mice develop GDM from beta cell dysfunction. βArnt and control female mice were used to induce GDM and non-diabetic pregnancies, respectively. RESULTS: Offspring from GDM pregnancies became spontaneously obese on a normal-chow diet. They were heavier than offspring from non-diabetic pregnancies, with increased body fat. Respiratory exchange ratio (RER) was higher, indicating decreased capacity to switch to lipid oxidation. Metabolic rate in GDM offspring was decreased prior to onset of obesity. The phenotype was more pronounced in βArnt GDM offspring than in GDM offspring of control genotype, demonstrating an interaction between genotype and pregnancy exposure. βArnt GDM offspring had increased hypothalamic neuropeptide Y (Npy) and decreased pro-opiomelanocortin (Pomc) expression. Weight, body fat, insulin sensitivity and RER in all mice, and hypothalamic Npy in βArntmice were significantly correlated with AUC of maternal late pregnancy glucose tolerance tests (p < 0.01), but not with litter size, maternal weight, triacylglycerol or pre-pregnancy glycaemia. CONCLUSIONS/ INTERPRETATION: In βArntmice, exposure to GDM and inheritance of genetic beta cell dysfunction had additive effects on male offspring obesity; severity of the offspring phenotype correlated with maternal glycaemia.
Authors: N Shaat; E Karlsson; A Lernmark; S Ivarsson; K Lynch; H Parikh; P Almgren; K Berntorp; L Groop Journal: Diabetologia Date: 2006-04-26 Impact factor: 10.122
Authors: Caroline A Crowther; Janet E Hiller; John R Moss; Andrew J McPhee; William S Jeffries; Jeffrey S Robinson Journal: N Engl J Med Date: 2005-06-12 Impact factor: 91.245
Authors: D Dabelea; R L Hanson; R S Lindsay; D J Pettitt; G Imperatore; M M Gabir; J Roumain; P H Bennett; W C Knowler Journal: Diabetes Date: 2000-12 Impact factor: 9.461
Authors: Steven R Gill; Mihai Pop; Robert T Deboy; Paul B Eckburg; Peter J Turnbaugh; Buck S Samuel; Jeffrey I Gordon; David A Relman; Claire M Fraser-Liggett; Karen E Nelson Journal: Science Date: 2006-06-02 Impact factor: 47.728
Authors: Jenny E Gunton; Mary Sisavanh; Rebecca A Stokes; Jon Satin; Leslie S Satin; Min Zhang; Sue M Liu; Weikang Cai; Kim Cheng; Gregory J Cooney; D Ross Laybutt; Trina So; Juan-Carlos Molero; Shane T Grey; Douglas A Andres; Michael S Rolph; Charles R Mackay Journal: PLoS One Date: 2012-06-28 Impact factor: 3.240
Authors: Sue Mei Lau; Kuan Minn Cha; Ayesha Karunatillake; Rebecca A Stokes; Kim Cheng; Mark McLean; N W Cheung; Frank J Gonzalez; Jenny E Gunton Journal: PLoS One Date: 2013-10-24 Impact factor: 3.240
Authors: Christian M Girgis; Kuan Minn Cha; Benjamin So; Michael Tsang; Jennifer Chen; Peter J Houweling; Aaron Schindeler; Rebecca Stokes; Michael M Swarbrick; Frances J Evesson; Sandra T Cooper; Jenny E Gunton Journal: J Cachexia Sarcopenia Muscle Date: 2019-06-21 Impact factor: 12.910
Authors: Corinna Grasemann; Maureen J Devlin; Paulina A Rzeczkowska; Ralf Herrmann; Bernhard Horsthemke; Berthold P Hauffa; Marc Grynpas; Christina Alm; Mary L Bouxsein; Mark R Palmert Journal: PLoS One Date: 2012-11-28 Impact factor: 3.240
Authors: Christopher H Scott; Kuan-Minn Cha; Jason Ngai; Changtao Jiang; Kim Cheng; Rebecca A Stokes; Kenneth W K Ho; Jacob George; Frank J Gonzalez; Jenny E Gunton Journal: PLoS One Date: 2017-11-30 Impact factor: 3.240